Page last updated: 2024-10-25

citalopram and Myeloproliferative Disorders

citalopram has been researched along with Myeloproliferative Disorders in 1 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research Excerpts

ExcerptRelevanceReference
"To report a case of serotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl."7.74Serotonin syndrome caused by interaction between citalopram and fentanyl. ( Ailawadhi, S; Baer, MR; Carlson, LA; Sung, KW, 2007)
"To report a case of serotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl."3.74Serotonin syndrome caused by interaction between citalopram and fentanyl. ( Ailawadhi, S; Baer, MR; Carlson, LA; Sung, KW, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ailawadhi, S1
Sung, KW1
Carlson, LA1
Baer, MR1

Other Studies

1 other study available for citalopram and Myeloproliferative Disorders

ArticleYear
Serotonin syndrome caused by interaction between citalopram and fentanyl.
    Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:2

    Topics: Aged; Citalopram; Drug Interactions; Drug Therapy, Combination; Fentanyl; Humans; Myelodysplastic Sy

2007